Levetiracetam Tablet, Film Coated
Product Images NDC 70518-1108

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-1108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Levetiracetam 500 mg film-coated tablets packaging label shows the product name with highlighted strength and dosage form. The label indicates a quantity of 30 tablets, is marked RX only, and includes NDC 70518-1108-00. The manufacturer listed is Lupin Pharma, Baltimore, MD, with repackaging by RemedyRepack Inc., Indiana, PA. Storage instructions and a QR code are also visible.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 01

A dosing calculation formula for Levetiracetam, showing total daily dose (mL/day) equals daily dose in mg/kg/day times patient weight in kg divided by 100 mg/mL concentration. This panel is related to oral dosage calculations for Levetiracetam 500 mg film-coated tablets by RemedyRepack Inc.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 02

A text panel showing the formula to calculate creatinine clearance (CLcr) adjusted for age, weight, serum creatinine, and body surface area (BSA), including a multiplication factor for female patients. It details how to adjust CLcr for body surface area in mL/min/1.73 m².*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 03

Chemical structure of levetiracetam, showing the molecular arrangement of the active ingredient in the drug.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 04

A bar chart showing the percentage of patients with a given response for Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The y-axis represents the percentage of patients from 0% to 45%, with Placebo at 7.4%, Levetiracetam 1000 mg/day at 37.1%, and Levetiracetam 3000 mg/day at 39.6%. Each bar is labeled with the total number of patients in each group (Placebo N=95, Levetiracetam 1000 mg/day N=97, Levetiracetam 3000 mg/day N=101).*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 05

A bar chart depicting the percentage of patients across three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). Patient sample sizes are 111 for placebo and 106 for each Levetiracetam group. The chart illustrates increased response with higher Levetiracetam doses.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 06

A bar graph comparing the percentage of patients showing a response between a placebo group and a Levetiracetam 3000 mg/day group. The y-axis represents the percentage of patients, with values labeled for placebo at 14.4% and Levetiracetam at 39.4%, indicating a higher response rate in the Levetiracetam group.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 07

A bar chart comparing the percentage of patients between two groups: Placebo (N=97) with 19.6% and Levetiracetam (N=101) with 44.6%. The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 08

A bar chart showing the percentage of patients in two groups: Placebo (N=51) with 19.6% and Levetiracetam (N=58) with 43.1%. The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 09

A bar chart comparing the percentage of patients between two groups: Placebo (N=84) with 45.2%, and Levetiracetam (N=79) with 72.2%. The y-axis represents the percentage of patients from 0% to 100%. An asterisk is shown above the Levetiracetam bar.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.